Advances in Postpartum Depression: What You Need to Know

Advances in Postpartum Depression: What You Need to Know

CME/CE Broadcast Replay

Advances in Postpartum Depression: What You Need to Know

Exciting new agents are emerging to treat PPD. Tune in to make sure you’re doing all you can to screen for PPD and improve outcomes for your patients.

Available credits: 0.50

Time to complete: 30 minutes


Valid until:

Take Post-Test

If you’ve already completed the activity.

  • Overview

    Listen in as Dr. Anita Clayton takes us through the importance of screening for postpartum depression (PPD) and reaching an early diagnosis in the perinatal and postnatal stages of pregnancy. This Women’s Health 2021 lecture also covers the exciting new agents that are targeted specifically for PPD. Find out how they compare to the traditional antidepressants and how they can improve the quality of life for your patients with PPD.

  • Disclosure of Conflicts of Interest

    In accordance with the ACCME Standards for Integrity and Independence, Global Learning Collaborative (GLC) requires that individuals in a position to control the content of an educational activity disclose all relevant financial relationships with any ineligible company. GLC mitigates all conflicts of interest to ensure independence, objectivity, balance, and scientific rigor in all its educational programs.

    Anita H. Clayton, MD
    Professor & Chair
    Department of Psychiatry and Neurobehavioral Sciences
    University of Virginia
    Charlottesville, VA

    Contracted Research: Daré Bioscience, Janssen, Relmada Therapeutics, Inc., Sage Therapeutics
    Consulting Fees: Fabre-Kramer; Janssen Research & Development, LLC.; Mind Cure Health; Ovoca Bio; PureTech Health; S1 Biopharma; Sage Therapeutics; Takeda/Lundbeck; Vella Bioscience, Inc; WCG MedAvante-ProPhase
    Ownership Interest: Euthymics, Mediflix LLC, S1 Biopharma
    Royalty: Ballantine Books/Random House; Changes in Sexual Functioning Questionnaire; Guilford Publications 

    Reviewers/Content Planners/Authors:

    • Nick Lombardi has nothing relevant to disclose.
    • Libby Lurwick has nothing to disclose.
    • Brian P. McDonough, MD, FAAFP, has nothing to disclose.
    • Kate Nagele has nothing to disclose.
    • Jessica Runyon has nothing to disclose.
  • Learning Objectives

    After participating in this educational activity, participants should be better able to:

    • Describe validated tools for identifying patients with postpartum depression
    • Outline the current evidence-based strategies for optimal treatment of mild, moderate, and severe postpartum depression
    • Discuss the efficacy and safety findings from clinical trials of approved and emerging therapies for postpartum depression

  • Target Audience

    This activity is designed to meet the educational needs of physicians, nurse practitioners, and physician assistants in the fields of obstetrics and gynecology, primary care, and psychiatry

  • Accreditation and Credit Designation Statements

    In support of improving patient care, Global Learning Collaborative (GLC) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

    Global Learning Collaborative (GLC) designates this enduring activity for a maximum of .5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    Global Learning Collaborative (GLC) designates this activity for .5 nursing contact hours. Nurses should claim only the credit commensurate with the extent of their participation in the activity.

  • Provider(s)/Educational Partner(s)

    Omnia Education is the leading provider of education for women’s health professionals. Our activities are recognized nationwide for providing credible, relevant, and practical information on issues impacting the female patient. Additionally, our unique focus has transformed the CME learning environment, and our ability to help learners recognize and overcome barriers to optimal performance and optimal patient outcomes has positioned us as a leader in women’s health education.

  • Commercial Support

    This activity is supported by an independent educational grant from Sage Therapeutics, Inc.

  • Disclaimer

    The views and opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of GLC and Omnia Education. This presentation is not intended to define an exclusive course of patient management; the participant should use his/her clinical judgment, knowledge, experience, and diagnostic skills in applying or adopting for professional use any of the information provided herein. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patients’ conditions and possible contraindications or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities. Links to other sites may be provided as additional sources of information. Once you elect to link to a site outside of Omnia Education you are subject to the terms and conditions of use, including copyright and licensing restriction, of that site.

    Reproduction Prohibited
    Reproduction of this material is not permitted without written permission from the copyright owner.

  • System Requirements

    Our site requires a computer, tablet, or mobile device and a connection to the Internet. For best results, a high-speed Internet connection is recommended (DSL/Cable/Fibre). We also recommend using the latest version of your favorite browser to ensure compliance with W3C standards, such as Chrome, Safari, Firefox, or Microsoft Edge.

Facebook Comments


We’re glad to see you’re enjoying Omnia Education…
but how about a more personalized experience?

Register for free